hcp.aggrenox.com
Aggrenox
https://hcp.aggrenox.com/esps2-safety-findings.html
Prescribing Information, Including Patient Information. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. AGGRENOX should be avoided during pre...
hcp.aggrenox.com
Aggrenox
https://hcp.aggrenox.com/?campaign_source=referrer&campaign_medium=www.aggrenoxhcp.com&campaign_name=HCPtoPatient
Prescribing Information, Including Patient Information. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Prescribed for over 15 years. Patients get the brand you've chosen for less*. Get your patients started with Door to Door. Commercially insured patients may pay as little as $10. Free, convenient delivery:. See Terms and Conditions. AGGRENOX inc...
hcp.aggrenox.com
Aggrenox
https://hcp.aggrenox.com/clinical-studies.html
Prescribing Information, Including Patient Information. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. AGGRENOX should be avoided during pre...
hcp.aggrenox.com
Aggrenox
https://hcp.aggrenox.com/aggrenox-savings-card.html
Prescribing Information, Including Patient Information. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. AGGRENOX should be avoided during pre...
hcp.aggrenox.com
Aggrenox
https://hcp.aggrenox.com/taking-smart-steps.html
Prescribing Information, Including Patient Information. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. AGGRENOX should be avoided during pre...
hcp.aggrenox.com
Aggrenox
https://hcp.aggrenox.com/european-stroke-prevention-study-2.html
Prescribing Information, Including Patient Information. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. AGGRENOX should be avoided during pre...
hcp.aggrenox.com
Aggrenox
https://hcp.aggrenox.com/mechanism-of-action.html
Prescribing Information, Including Patient Information. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. AGGRENOX should be avoided during pre...
hcp.aggrenox.com
Aggrenox
https://hcp.aggrenox.com/tia-is-an-emergency.html
Prescribing Information, Including Patient Information. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. AGGRENOX should be avoided during pre...
hcp.aggrenox.com
Aggrenox
https://hcp.aggrenox.com/tia-stroke-treatment-guidelines.html
Prescribing Information, Including Patient Information. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. Aspirin/extended-release dipyridamole) 25 mg/200 mg capsules is indicated to reduce the risk of stroke in patients who have had transient ischemia of the brain or completed ischemic stroke due to thrombosis. AGGRENOX should be avoided during pre...